-
Biotech Stocks Touched New Lows: Arrowhead Research Corp. (NASDAQ:ARWR), Theravance Biopharma (NASDAQ:TBPH), Recro Pharma (NASDAQ:REPH), ARCA biopharma (NASDAQ:ABIO), Lpath (NASDAQ:LPTN)
Arrowhead Research Corp. (NASDAQ:ARWR) on 24 November reported a fiscal fourth-quarter loss of $22.4 million. The Pasadena, California-based company said it had a loss of 42 cents per share. Losses, adjusted for non-recurring costs and asset impairment costs, came to 33 cents per share. The results fell short of Wall Street expectations. The average estimate…
-
Morning Alert: The Dow Chemical Company (NYSE:DOW), Ubiquiti Networks (NASDAQ:UBNT), CEL-SCI Corporation (NYSEMKT:CVM), Theravance Biopharma (NASDAQ:TBPH), B/E Aerospace Inc. (NASDAQ:BEAV)
On 21 November The Dow Chemical Company (NYSE:DOW) and Third Point LLC have reportedly settled a long-running dispute concerning the addition of members to Dow Chemical’s board. The Dow Chemical Company (NYSE:DOW) in last trading activity fell -4.87% to close at $49.24. Company weekly performance is -4.35% while its quarterly performance stands at -7.41%. The…
-
Top News: Brocade Communications Systems (NASDAQ:BRCD), Ctrip.com International (NASDAQ:CTRP), Sevcon (NASDAQ:SEV), LGL Group (NYSEMKT:LGL), Theravance Biopharma (NASDAQ:TBPH)
Brocade Communications Systems (NASDAQ:BRCD) declared a quarterly dividend on Monday, November 24th, AnalystRatingsNetwork reports. Shareholders of record on Wednesday, December 10th will be given a dividend of 0.035 per share on Friday, January 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 1.20%.Brocade Communications Systems, Inc. (NASDAQ:BRCD) in last trading…
-
Today’s Watch List: Merck & Co. Inc. (NYSE:MRK), Exelon Corporation (NYSE:EXC), MDU Resources Group Inc. (NYSE:MDU), Theravance Biopharma (NASDAQ:TBPH), Activision Blizzard (NASDAQ:ATVI)
Merck & Co. Inc. (NYSE:MRK)’s pills Zetia and Vytorin generated more than $21 billion for the company since they were introduced more than a decade ago. Next week, doctors will find out if they actually save lives in addition to lowering cholesterol. Merck & Co. Inc. (NYSE:MRK) in last trading activity decreased -0.10% to close…
-
Trader’s Watch List: Theravance Biopharma (NASDAQ:TBPH), Advanced Micro Devices (NYSE:AMD), Senomyx Inc. (NASDAQ:SNMX), Compuware Corporation (NASDAQ:CPWR), AEGON N.V. (NYSE:AEG)
On 3 November Theravance Biopharma, Inc. (NASDAQ:TBPH) announced positive results from the first three cohorts of Study 0110, a Phase 1 proof-of-concept study of TD-6450, a next-generation investigational NS5A inhibitor in development to treat patients with hepatitis C virus infection (HCV). Theravance Biopharma, Inc. (NASDAQ:TBPH) in last trading activity moved down -0.73% to close at…
-
Eye Catching Stocks: SodaStream International (NASDAQ:SODA), Google Inc (NASDAQ:GOOG), Alexco Resource Corporation (NYSEMKT:AXU), Theravance Biopharma(NASDAQ:TBPH), LinkedIn Corporation (NYSE:LNKD)
SodaStream International Ltd (NASDAQ:SODA) just confirmed earlier reports that it has struck a deal with Pepsi (NYSE: PEP), calling the deal a ‘small-scale, limited time test. SodaStream International Ltd. (NASDAQ:SODA) in last trading activity increased 15.38% to close at $24.45. Company weekly performance is 16.43% while its quarterly performance stands at -20.92%. SodaStream International Ltd.…
-
Hot Alert : Streamline Health. (NASDAQ:STRM), Crown Castle International (NYSE:CCI), GreenHunter Resources, Inc. (NYSEMKT:GRH), Dipexium Pharmaceuticals (NASDAQ:DPRX), Theravance Biopharma (NASDAQ:TBPH)
Streamline Health Solutions Inc. (NASDAQ:STRM) CEO Robert Eugene Watson bought 10,000 shares of the company’s stock in a transaction dated Thursday, August 21st. The stock was purchased at an average price of $4.28 per share, for a total transaction of $42,800.00. Following the purchase, the chief executive officer now directly owns 205,798 shares of the…